- Summary of Prioritized Research Needs
- 2.4.1 Overview
- 2.4.2 Research Needs
- Defining the general measures of successful program implementation.
- Optimizing effectiveness of drug distribution strategies.
- Program implementation in urban areas.
- Program implementation in L. loa-endemic areas.
- Program upscaling/downscaling.
- Disability prevention (disease management).
- Social mobilization.
- Integrating LF elimination with other disease control programs.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Ottesen, EA, 2000. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 5 :591–594.
-
2
World Health Organization, 2003. Global Programme to Eliminate Lymphatic Filariasis: Annual Report on Lymphatic Filariasis 2003. Geneva: Geneva: World Health Organization, 145–147, www.filariasis.org.
-
3
World Health Organization, 2004. Global Programme for the Elimination of Lymphatic Filariasis Strategic Plan 2003–2005: Challenges of Scaling Up. Geneva: World Health Organization, www.filariasis.org.
-
4
Houston, R, 2000. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Parasitology 121 (Suppl):161–173.
-
5
Boussinesq M, Gardon J, 1997. Prevalences of Loa loa microfilaremia throughout the area endemic for the infection. Ann Trop Med Parasitol 91 :573–589.
-
6
Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux J-P, 1997. Serious reactions after mass treatment with ivermectin in an area endemic for Loa loa infection. Lancet 350 :18–22.
-
7
Joint Action Forum, Fifth Session, 2000. African Programme for Onchocerciasis Control. Ouagadougou, Burkina Faso, 2.
-
8
Stolk, WA, Subramanian, S, van Oortmarssen, GJ, Das PK, Habbema JD, 2003. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a stimulation study. J Infect Dis 188 :1371–1381.
-
9
World Health Organization, 2002. The Global Elimination of Lymphatic Filariasis: The Story of Zanzibar. Geneva: World Health Organization, 14–15.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 178 | 150 | 5 |
| Full Text Views | 265 | 3 | 0 |
| PDF Downloads | 29 | 3 | 0 |
2.4 PROGRAM IMPLEMENTATION
Mwele Malecela-Lazaro
Mwele Malecela-Lazaro
Search for other papers by Mwele Malecela-Lazaro in
Current site
Google Scholar
PubMed
Search for other papers by Mwele Malecela-Lazaro in
Current site
Google Scholar
PubMed
Nana Twum-Danso
Nana Twum-Danso
Search for other papers by Nana Twum-Danso in
Current site
Google Scholar
PubMed
Search for other papers by Nana Twum-Danso in
Current site
Google Scholar
PubMed
Author Notes
- Summary of Prioritized Research Needs
- 2.4.1 Overview
- 2.4.2 Research Needs
- Defining the general measures of successful program implementation.
- Optimizing effectiveness of drug distribution strategies.
- Program implementation in urban areas.
- Program implementation in L. loa-endemic areas.
- Program upscaling/downscaling.
- Disability prevention (disease management).
- Social mobilization.
- Integrating LF elimination with other disease control programs.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Ottesen, EA, 2000. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 5 :591–594.
-
2
World Health Organization, 2003. Global Programme to Eliminate Lymphatic Filariasis: Annual Report on Lymphatic Filariasis 2003. Geneva: Geneva: World Health Organization, 145–147, www.filariasis.org.
-
3
World Health Organization, 2004. Global Programme for the Elimination of Lymphatic Filariasis Strategic Plan 2003–2005: Challenges of Scaling Up. Geneva: World Health Organization, www.filariasis.org.
-
4
Houston, R, 2000. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Parasitology 121 (Suppl):161–173.
-
5
Boussinesq M, Gardon J, 1997. Prevalences of Loa loa microfilaremia throughout the area endemic for the infection. Ann Trop Med Parasitol 91 :573–589.
-
6
Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux J-P, 1997. Serious reactions after mass treatment with ivermectin in an area endemic for Loa loa infection. Lancet 350 :18–22.
-
7
Joint Action Forum, Fifth Session, 2000. African Programme for Onchocerciasis Control. Ouagadougou, Burkina Faso, 2.
-
8
Stolk, WA, Subramanian, S, van Oortmarssen, GJ, Das PK, Habbema JD, 2003. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a stimulation study. J Infect Dis 188 :1371–1381.
-
9
World Health Organization, 2002. The Global Elimination of Lymphatic Filariasis: The Story of Zanzibar. Geneva: World Health Organization, 14–15.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 178 | 150 | 5 |
| Full Text Views | 265 | 3 | 0 |
| PDF Downloads | 29 | 3 | 0 |